SkinBioTherapeutics plc (SBTX) Ord GBP0.01
0.35p
(5.51%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.35p
(5.51%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.35p
(5.51%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
6.25p
6.50p
27.50p
£15.55 million
6.35p
5.60p
5.75p
n/a
0.35p (5.83%) Previous:
0.35p
4,407,885
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/06/2025 | 30/06/2024 |
|---|---|---|
| Revenue (£m) | 4.64 | 1.21 |
| Profit before tax (£m) | (0.72) | (2.95) |
| Adjusted EPS (p): | (0.31) | (1.54) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
SkinBioTherapeutics dives on warning of major FY25 revenue restatement
16 February 2026 08:53
-
SkinBioTherapeutics CEO resigns
13 February 2026 07:56
-
SkinBioTherapeutics revenue rises fourfold, still misses forecasts
14 August 2025 13:48
-
Update on Board Investigation
16 February 2026 07:00
-
Resignation of CEO
13 February 2026 07:00
-
Holding(s) in Company
12 February 2026 11:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.